Spyre Therapeutics, Inc. (SYRE): 8-K filed Sep 8, 2026

Form type

8-K

Filing date

Sep 8, 2026

Accession number

0001636282-26-000113

Filer

Spyre Therapeutics, Inc. (CIK 1636282)